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A novel pathogenic taxon of the Mycobacte-
rium tuberculosis complex was described (1) in
1997 in a highly exceptional strain, designated
So93, isolated in 1993 from a 2-year-old Somali
child with lymphadenitis. Although on the basis
of biochemical tests and the 16S rRNA gene
sequence this isolate was clearly a member of the
M. tuberculosis complex, it exhibited an unusually
smooth and glossy colony morphology. Genetically,
strain So93 differed from all known M. tuberculosis
complex strains (nearly 2,000 M. tuberculosis
isolates have been examined) (1). It contained a
single copy of the insertion sequence IS1081, had a
direct repeat region with an exceptional composi-
tion, and differed in the sequence of the recA gene.
In 1969, Canetti had isolated from a French patient
an  M. tuberculosis strain with a smooth colony
morphology. Daffé et al. (2) had demonstrated that
this particular strain differed from the commonly
rough strains by having large amounts of
lipooligosaccharides. Isolate So93 and the Canetti
strain from the 1960s shared virtually all
phenotypic and genetic characteristics. There-
fore, these two smooth M. tuberculosis variants
were designated M. canettii (1).
We report here a third tuberculosis (TB) case
caused by M. canettii. The mycobacterial isolate
NZM 217/94 was cultured from pus aspirated
from the ileocecal region of a 56-year-old male
patient born in Switzerland. Phenotypic and
genetic characteristics were compared with both
the isolate So93 and the Canetti strain.
The patient had been working for an
international organization since 1963, in
Uganda for 20 years, then in Kenya for 1 year.
HIV infection was detected in this patient in
1993. That same year, he contracted pneumonia
of unknown etiology, which was successfully
treated with cotrimoxazole. Two short episodes
of severe diarrhea followed in 1994. The patient
was transferred from Kenya to the University
Hospital in Geneva, where a partial occlusion of
the ileum caused by an extrinsic compression
was diagnosed. A right hemicolectomy was
performed. An extensive inflammatory mass of
mesenteric lymph nodes was strongly positive
for acid-fast bacilli by direct microscopy. After as
little as 1 week, culture (BACTEC 12B medium;
Becton Dickinson Diagnostic Instrument Sys-
tems, Sparks, MD) yielded mycobacteria, which
were identified as M. tuberculosis complex. The
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An exceptionally smooth and glossy morphotype of Mycobacterium tuberculosis
complex was isolated from a 56-year-old Swiss patient with mesenteric tuberculosis.
Direct 16S rRNA sequence analysis of the hypervariable signature gene regions
revealed a 100% homology to the specific M. tuberculosis complex sequence.
Spoligotyping and restriction fragment length polymorphism analyses using the
insertion sequences IS6110 and IS1081 and the polymorphic GC-rich sequence as
additional genetic markers identified the isolate as the novel taxon M. canettii. Like a
Somali child with a similar case, this patient probably contracted the infection in Africa,
which raises questions about the geographic distribution of M. canettii.632 Emerging Infectious Diseases Vol. 4, No. 4, OctoberDecember 1998
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patient was already in stage C2 of AIDS, which
favored a rapid development of mesenteric
disease. No pulmonary signs of the disease were
observed (3). Response to quadruple
antituberculotic chemotherapy was excellent.
However, within 3 months, extensive cutaneous
lesions developed due to a generalized highly
malignant non-Hodgkin lymphoma, another
complication of AIDS, known as fulminant disease
with poor prognosis. A cytostatic therapy was
initiated. The patient returned to Kenya but did
not follow any treatment regimens. He was
hospitalized in Geneva in 1995 with severe
cachexia and died 9 months later. The postmortem
findings showed massive invasion of the abdominal
cavity with malignant lymphoma but no further
evidence of active TB, neither by histology nor by
culture.
Although the isolate exhibited abundant
smooth and glossy colonies on Middlebrook 7H10
agar (Figure 1), the M. tuberculosis complex
gene probe (Accuprobe; Gen-Probe Inc., San
Diego, CA) was positive. Growth was strictly
aerobic. The strain reduced nitrate, but niacin
production and 68°C catalase were negative.
Analysis of cellular fatty acids was done by gas-
liquid chromatography in conjunction with the
Microbial Identification System (Microbial ID
Inc., Newark, DE) (4) and yielded M. tuberculosis
complex. Cellular fatty acid esters ranged from
C12:0 to C20:0, the major components being
C16:0 (35.5%), C18:1 (24.9%), C18:0 (11.2%), and
tuberculostearic acid (10 Me-18:0 TBSA; 12.1%).
Mycolic acids consisted of a, methoxy, and keto
mycolates, which are typical for tubercle bacilli.
Guanine plus cytosine content of the DNA was
66.4 mol%. The polymerase chain reaction/
restriction enzyme pattern of the amplified 65-
kDa heat shock protein gene fragment (65-kDa-
HSP-PRA) (5) yielded bands of 245/125/80 bp and
of 160/140/70 bp, respectively, following BstEII
and HaeIII digests, a pattern compatible with
M. tuberculosis complex (5). Direct 16S rDNA
sequence analysis (6) showed that the
hypervariable signature gene regions were
identical to M. tuberculosis complex.
Strain NZM 217/94 was susceptible to p-nitro-
a-acetylamino-ß-hydroxypropiophenone (NAP) (7)
and thiophene carboxylic acid (T2H) as well as to all
primary antituberculotic drugs (isoniazid 0.2 and
1µg/ml, rifampin 0.2 µg/ml, ethambutol 2.5 µg/ml),
except pyrazinamide (100 µg/ml). Susceptibility
was observed against the second-line drugs
streptomycin (10 µg/ml), ethionamide (5 µg/ml),
rifabutin (1 µg/ml), sparfloxacin (1 µg/ml),
ofloxacin (1 µg/ml), ciprofloxacin (1 µg/ml), and p-
amino salicylic acid (2 µg/ml). Susceptibility testing
of the primary antituberculotics was done
radiometrically (BACTEC 460TB System,
Becton Dickinson) (8). Second-line drugs have
been tested by the method of proportion
(indirect test) on Middlebrook 7H10 agar (9).
To determine whether the isolate from the
Swiss patient represented the M. canettii
genotype, restriction fragment length polymor-
phism (RFLP) analyses and spoligotyping were
performed (1,10). The IS6110 RFLP patterns of
the Swiss (NZM 217/94) and the Somali isolates
(So93) were identical (Figure 2a). As previously
shown, the Canetti isolate contains an additional
copy of this insertion sequence. Furthermore,
the Swiss isolate contains a single copy of IS1081
on a similarly sized PvuII restriction fragment,
as previously found in the So93 strain (Figure 2b).
The patterns generated with the polymorphic
GC-rich repetitive sequence (PGRS) of strains
NZM 217/94 and So93 were identical; whereas
for the Canetti strain, 7 out of 20 PGRS-
containing AluI restriction fragments were
found at other positions (data not shown). By
the recently developed spoligotyping tech-
nique (10) we could demonstrate that the Swiss
isolate contained the same two spacer
sequences found in both the Canetti strain and
the So93 isolate (Figure 2c).
Figure 1. Colony morphology of strain NZM 217/94 on
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These data demonstrate the first TB case
caused by M. canettii in a Swiss patient. RFLP
analyses using IS6110, IS1081, and PGRS as
probes as well as spoligotyping revealed the
same DNA fingerprint patterns for the Swiss
isolate as previously found for strain So93
isolated from a Somali child. With its highly
exceptional smooth and glossy colony morphol-
ogy and the unusual, abundant growth, the
Swiss isolate belongs to the same taxon of the
M. tuberculosis complex as the Somali isolate
and the Canetti strain. The Canetti strain
isolated in France about 30 years ago (from a
patient of whom no further details are available)
showed RFLP patterns that were highly similar
but not identical to the ones of the Swiss and
Somali isolates. Our data indicate 1) that the
M. canettii taxon comprises strains with some
degree of evolutionary divergence and 2) that
this evolutionary lineage already existed but was
Figure 2. IS6110 (a) and IS1081 (b) hybridization patterns of PvuII-digested genomic DNA. Lanes 1 to 3: clinical
M. tuberculosis isolates; lane 4: the Somali isolate, So93; lane 5: the Canetti strain isolated in France in 1969;
lane 6: the Swiss isolate, NZM 217/94; lane 7: M. tuberculosis Mt14323 (reference strain). Figure c represents
spoligotyping patterns. Lane 1: M. tuberculosis H37Rv (reference strain); lane 2: the Canetti strain; lane 3: the
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likely overlooked because the lack of adequate
genetic characterization techniques.
Although the exact source of infection in this
latest clinical case of M. canettii could not be
established with certainty, the patient was
repeatedly exposed to TB patients in East Africa.
Since the patient had no known exposure to pets
or wild animals, a human source of infection
seems very likely. This report indicates that
M. canettii may be of wider prevalence than
previously thought; therefore, further studies
are needed to determine its geographic
distribution (i.e., its reservoir) and eventually
the extent of genetic variation and presence of
virulence factors associated with this particular
taxon of the M. tuberculosis complex. In
addition, this study demonstrates the value of
applying a combination of several subtyping
methods by which future studies can be directed
to determine whether M. canettii is emerging as
an important pathogen.
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